OTCM
CZMWY
Market cap3.06bUSD
Oct 08, Last price
34.98USD
1D
-1.74%
1Q
0.34%
Jan 2017
-4.10%
IPO
161.04%
Name
Carl Zeiss Meditec AG
Chart & performance
P/E
19.34
P/S
1.23
EPS
1.61
Div yield, %
1.85%
Shrs. gr., 5y
-0.43%
Rev. gr., 5y
10.78%
Revenues
2.23b
+7.82%
Net income
141m
-20.99%
CFO
210m
-15.15%
Dividend
Mar 30, 20260.62942 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeutic management of ocular conditions, including specialized systems and essential consumables for cataract, retinal, and refractive surgical procedures. This division serves ophthalmologists, optometrists, and medical and surgical professionals in hospitals and ambulatory surgery centers. The Microsurgery segment focuses on delivering advanced visualization tools vital for intricate surgical interventions, additionally supplying specialized solutions for ear, nose, and throat (ENT), plastic and reconstructive, dental, and spinal surgeries. This segment supports a diverse group of medical practitioners across various disciplines, as well as healthcare institutions. Established in 1846 and headquartered in Jena, Germany, the company operates as a subsidiary of Carl Zeiss AG.
Related entities
Parent
Carl Zeiss AG
Subsidiaries (3)
Carl Zeiss Meditec Co., Ltd.
Carl Zeiss Meditec, Inc.
HYALTECH LTD.
Key people
Maximilien Foerst
Chairman of the Management Board, President, Chief Executive Officer · since 2025
Rene Denner
Deputy Chairman of the Supervisory Board - Employee Representative · since 2023
Justus Wehmer
Chief Financial Officer, Member of the Management Board · since 2018
Andreas Pecher
Chairman of the Supervisory Board · since 2025
Falk Bindheim
Member of the Supervisory Board - Employee Representative · since 2023
Member of the Supervisory Board · since 2025
Member of the Supervisory Board · since 2020
Peter Kameritsch
Member of the Supervisory Board · since 2021
Brigitte Koblizek
Member of the Supervisory Board - Employee Representative · since 2022
Heike Madan
Member of the Supervisory Board - Employee Representative · since 2023
Jeffrey Marx
Member of the Supervisory Board - Employee Representative · since 2020
Stefan Muller
Member of the Supervisory Board · since 2024
Christian Munster
Member of the Supervisory Board - Employee Representative · since 2023
Torsten Reitze
Member of the Supervisory Board · since 2021
IPO date
Mar 20, 2000
Employees
4,224
Domiciled in
DE
Incorporated in
DE
Headquarters & legal address
Göschwitzer Straße 51-52
Jena, TH 07745
DE
Jena, TH 07745
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||